Abstract
Cancer stem cells (CSCs), or cancer cells with stem cell properties, are a rare population of tumor bulk and are recognized to be responsible for cancer recurrence, drug resistance, and metastasis. However, the molecular mechanisms of how to regulate the differentiation and self-renewing of CSCs are poorly understood. Krüppel-like factors (KLFs) are essential DNA-binding transcriptional regulators with diverse functions in various cellular processes, including differentiation, proliferation, inflammation, migration, and pluripotency. Recent progress has highlighted the significance of KLFs in tumor progression and CSCs. The regulatory functions of KLFs in the development of cancer and CSCs have become a burgeoning area of intense research. In this review, we summarize the current understanding and progress of the transcriptional regulation of KLFs in CSCs and discuss the functional implications of targeting CSCs by KLFs for cancer therapeutics.
Similar content being viewed by others
References
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983–3988
Baccelli I, Trumpp A (2012) The evolving concept of cancer and metastasis stem cells. J Cell Biol 198:281–293
Bin Z, Ke-Yi L, Wei-Feng Z et al (2013) Downregulation of KLF8 expression by shRNA induces inhibition of cell proliferation in CAL27 human oral cancer cells. Med Oral Patol Oral Cir Bucal 18:e591–e596
Cabarcas SM, Mathews LA, Farrar WL (2011) The cancer stem cell niche—there goes the neighborhood. Int J Cancer 129:2315–2327
Cai XD, Zhou YB, Huang LX et al (2012) Reduced expression of Kruppel-like factor 17 is related to tumor growth and poor prognosis in lung adenocarcinoma. Biochem Biophys Res Commun 418:67–73
Camacho-Vanegas O, Till J, Miranda-Lorenzo I, Ozturk B, Camacho SC, Martignetti JA (2013) Shaking the family tree: identification of novel and biologically active alternatively spliced isoforms across the KLF family of transcription factors. FASEB J 27:432–436
Chakroborty D, Sarkar C, Yu H et al (2011) Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells. Proc Natl Acad Sci U S A 108:20730–20735
Chang VH, Chu PY, Peng SL et al (2012) Kruppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma. Am J Pathol 181:423–430
Chen C, Benjamin MS, Sun X et al (2006) KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line. Int J Cancer 118:1346–1355
Chen C, Bhalala HV, Vessella RL, Dong JT (2003) KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate 55:81–88
Chen H, Chen L, Sun L, Zhen H, Li X, Zhang Q (2011) A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer. Gastric Cancer 14:339–352
Chen K, Chen Y, Zhu XD et al (2012) Expression and significance of Kruppel-like factor 6 gene in osteosarcoma. Int Orthop 36:2107–2111
Chen J, Li Y, Yu TS et al (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522–526
Chen CJ, Lin SE, Lin YM, Lin SH, Chen DR, Chen CL (2012) Association of expression of Kruppel-like factor 4 and Kruppel-like factor 5 with the clinical manifestations of breast cancer. Pathol Oncol Res 18:161–168
Chiam K, Ryan NK, Ricciardelli C et al (2013) Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers. Prostate 73:182–193
Cho YG, Choi BJ, Kim CJ et al (2006) Genetic alterations of the KLF6 gene in colorectal cancers. APMIS 114:458–464
Clarke MF, Dick JE, Dirks PB et al (2006) Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339–9344
Dalerba P, Cho RW, Clarke MF (2007) Cancer stem cells: models and concepts. Annu Rev Med 58:267–284
Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275–284
Dereeper A, Guignon V, Blanc G et al (2008) Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res 36:W465–W469
Diakiw SM, Perugini M, Kok CH et al (2013) Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival. Br J Haematol 161:884–888
Dong P, Kaneuchi M, Xiong Y et al (2013) Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer. Carcinogenesis 5:760–768
Dong Z, Yang L, Lai D (2013) KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression. Cell Prolif 46:425–435
Driessens G, Beck B, Caauwe A, Simons BD, Blanpain C (2012) Defining the mode of tumour growth by clonal analysis. Nature 488:527–530
Faryna M, Konermann C, Aulmann S et al (2012) Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. FASEB J 26:4937–4950
Fernandez-Zapico ME, Mladek A, Ellenrieder V, Folch-Puy E, Miller L, Urrutia R (2003) An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation. EMBO J 22:4748–4758
Fu WJ, Li JC, Wu XY et al (2010) Small interference RNA targeting Kruppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo. J Cancer Res Clin Oncol 136:1255–1265
Funnell AP, Mak KS, Twine NA et al (2013) Generation of mice deficient in both KLF3/BKLF and KLF8 reveals a genetic interaction and a role for these factors in embryonic globin gene silencing. Mol Cell Biol 33:2976–2987
Gehrau RC, D’Astolfo DS, Dumur CI, Bocco JL, Koritschoner NP (2010) Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas. PLoS One 5:e8929
Giefing M, Wierzbicka M, Rydzanicz M, Cegla R, Kujawski M, Szyfter K (2008) Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors. Neoplasma 55:55–60
Gilbertson RJ, Graham TA (2012) Cancer: resolving the stem-cell debate. Nature 488:462–463
Ginestier C, Hur MH, Charafe-Jauffret E et al (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555–567
Gumireddy K, Li A, Gimotty PA et al (2009) KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol 11:1297–1304
Hao J, Zhang Y, Deng M et al (2014) MicroRNA control of epithelial-mesenchymal transition in cancer stem cells. Int J Cancer 135:1019–1027
Hao J, Zhao S, Zhang Y et al (2014) Emerging role of microRNAs in cancer and cancer stem cells. J Cell Biochem 115:605–610
Hart LS, El-Deiry WS (2008) Invincible, but not invisible: imaging approaches toward in vivo detection of cancer stem cells. J Clin Oncol 26:2901–2910
Hartel M, Narla G, Wente MN et al (2008) Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer. Eur J Cancer 44:1895–1903
He HJ, Gu XF, Xu WH, Yang DJ, Wang XM, Su Y (2013) Kruppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer. Acta Pharmacol Sin 34:282–288
Henson BJ, Gollin SM (2010) Overexpression of KLF13 and FGFR3 in oral cancer cells. Cytogenet Genome Res 128:192–198
Ho A, Fusenig N (2011) Cancer stem cells: a promising concept and therapeutic challenge. Int J Cancer 129:2309
Hoffmeyer K, Raggioli A, Rudloff S et al (2012) Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science 336:1549–1554
Hu R, Zuo Y, Zuo L et al (2011) KLF4 expression correlates with the degree of differentiation in colorectal cancer. Gut Liver 5:154–159
Huang D, Gao Q, Guo L et al (2009) Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines. Stem Cells Dev 18:465–473
Ivanov SV, Ivanova AV, Salnikow K, Timofeeva O, Subramaniam M, Lerman MI (2008) Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors. Biochem Biophys Res Commun 370:536–540
Jiang J, Chan YS, Loh YH et al (2008) A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol 10:353–360
Kang L, Lu B, Xu J, Hu H, Lai M (2008) Downregulation of Kruppel-like factor 9 in human colorectal cancer. Pathol Int 58:334–338
King KE, Iyemere VP, Weissberg PL, Shanahan CM (2003) Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem 278:11661–11669
Kreso A, Dick JE (2014) Evolution of the cancer stem cell model. Cell Stem Cell 14:275–291
Kwak MK, Lee HJ, Hur K et al (2008) Expression of Kruppel-like factor 5 in human gastric carcinomas. J Cancer Res Clin Oncol 134:163–167
Lai JK, Wu HC, Shen YC, Hsieh HY, Yang SY, Chang CC (2012) Kruppel-like factor 4 is involved in cell scattering induced by hepatocyte growth factor. J Cell Sci 125:4853–4864
Lapidot T, Sirard C, Vormoor J et al (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645–648
Le MC, Bubendorf L, Ruiz C et al (2013) Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells. Eur J Cancer 49:955–963
Leng Z, Tao K, Xia Q et al (2013) Kruppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells. PLoS One 8:e56082
Li Y, Kong D, Ahmad A, Bao B, Sarkar FH (2013) Pancreatic cancer stem cells: emerging target for designing novel therapy. Cancer Lett 338:94–100
Limame R, de Beeck KO, Lardon F, De Wever O, Pauwels P (2014) Kruppel-like factors in cancer progression: three fingers on the steering wheel. Oncotarget 5:29–48
Lin ZS, Chu HC, Yen YC, Lewis BC, Chen YW (2012) Kruppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression. PLoS One 7:e43593
Liu L, Liu N, Xu M et al (2012) Lentivirus-delivered Kruppel-like factor 8 small interfering RNA inhibits gastric cancer cell growth in vitro and in vivo. Tumour Biol 33:53–61
Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196:395–406
Lyng H, Brovig RS, Svendsrud DH et al (2006) Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics 7:268
Magee JA, Piskounova E, Morrison SJ (2012) Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21:283–296
Mani SA, Guo W, Liao MJ et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715
McConnell BB, Yang VW (2010) Mammalian Kruppel-like factors in health and diseases. Physiol Rev 90:1337–1381
Meyer SE, Hasenstein JR, Baktula A et al (2010) Kruppel-like factor 5 is not required for K-RasG12D lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival. Am J Pathol 177:1503–1513
Miettinen PJ, Ebner R, Lopez AR, Derynck R (1994) TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127:2021–2036
Miller IJ, Bieker JJ (1993) A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol 13:2776–2786
Miyoshi N, Ishii H, Nagai K et al (2010) Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci U S A 107:40–45
Mori A, Moser C, Lang SA et al (2009) Up-regulation of Kruppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha. Mol Cancer Res 7:1390–1398
Nagata S, Hirano K, Kanemori M, Sun LT, Tada T (2012) Self-renewal and pluripotency acquired through somatic reprogramming to human cancer stem cells. PLoS One 7:e48699
Nakahara Y, Northcott PA, Li M et al (2010) Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma. Neoplasia 12:20–27
Nakamura Y, Migita T, Hosoda F et al (2009) Kruppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression. Int J Cancer 125:1859–1867
Nandan MO, Ghaleb AM, McConnell BB, Patel NV, Robine S, Yang VW (2010) Kruppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations. Mol Cancer 9:63
Narla G, DiFeo A, Fernandez Y et al (2008) KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. J Clin Invest 118:2711–2721
Nguyen LV, Vanner R, Dirks P, Eaves CJ (2012) Cancer stem cells: an evolving concept. Nat Rev Cancer 12:133–143
Nishi M, Sakai Y, Akutsu H et al (2013) Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors. Oncogene. doi:10.1038/onc.2012.614
Okuda H, Xing F, Pandey PR et al (2013) miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res 73:1434–1444
Oskarsson T (2013) Extracellular matrix components in breast cancer progression and metastasis. Breast 22(Suppl 2):S66–S72
Ray A, Alalem M, Ray BK (2013) Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer. J Biol Chem 288:27232–27242
Reinholz MM, An MW, Johnsen SA et al (2004) Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer Res Treat 86:75–88
Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111
Sarig R, Rivlin N, Brosh R et al (2010) Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. J Exp Med 207:2127–2140
Schepers AG, Snippert HJ, Stange DE et al (2012) Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337:730–735
Schuh R, Aicher W, Gaul U et al (1986) A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Kruppel, a Drosophila segmentation gene. Cell 47:1025–1032
Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29
Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821–5828
Sun Z, Han Q, Zhou N et al (2013) MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma. Mol Oncol 7:884–894
Tahara E, Kadara H, Lacroix L, Lotan D, Lotan R (2009) Activation of protein kinase C by phorbol 12-myristate 13-acetate suppresses the growth of lung cancer cells through KLF6 induction. Cancer Biol Ther 8:801–807
Tai SK, Yang MH, Chang SY et al (2011) Persistent Kruppel-like factor 4 expression predicts progression and poor prognosis of head and neck squamous cell carcinoma. Cancer Sci 102:895–902
Tang SN, Fu J, Nall D, Rodova M, Shankar S, Srivastava RK (2012) Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int J Cancer 131:30–40
Taniguchi H, Jacinto FV, Villanueva A et al (2012) Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer. Oncogene 31:1988–1994
Tchirkov A, Sapin V, Marceau G et al (2010) Increased expression of the oncogenic KLF6-SV1 transcript in human glioblastoma. Clin Chem Lab Med 48:1167–1170
Teixeira MS, Camacho-Vanegas O, Fernandez Y et al (2007) KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma. Int J Cancer 121:1976–1983
Tetreault MP, Yang Y, Katz JP (2013) Kruppel-like factors in cancer. Nat Rev Cancer 13:701–713
Tiwari N, Meyer-Schaller N, Arnold P et al (2013) Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8). PLoS One 8:e57329
Vaira V, Faversani A, Martin NM et al (2013) Regulation of lung cancer metastasis by Klf4-Numb-like signaling. Cancer Res 73:2695–2705
Wang X, Lu H, Li T et al (2013) Kruppel-like factor 8 promotes tumorigenic mammary stem cell induction by targeting miR-146a. Am J Cancer Res 3:356–373
Wang X, Lu H, Urvalek AM et al (2011) KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene 30:1901–1911
Wang X, Urvalek AM, Liu J, Zhao J (2008) Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells. J Biol Chem 283:13934–13942
Wei D, Kanai M, Jia Z, Le X, Xie K (2008) Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res 68:4631–4639
Wellner U, Schubert J, Burk UC et al (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11:1487–1495
Wong CW, Hou PS, Tseng SF et al (2010) Kruppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells. Stem Cells 28:1510–1517
Wu XQ, Huang C, He X et al (2013) Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer. Cell Signal 25:2462–2468
Yamanaka S (2007) Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1:39–49
Yang T, Cai SY, Zhang J et al (2012) Kruppel-like factor 8 is a new Wnt/beta-catenin signaling target gene and regulator in hepatocellular carcinoma. PLoS One 7:e39668
Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14:818–829
Ying M, Sang Y, Li Y et al (2011) Kruppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells 29:20–31
Yori JL, Johnson E, Zhou G, Jain MK, Keri RA (2010) Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem 285:16854–16863
Yori JL, Seachrist DD, Johnson E et al (2011) Kruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia 13:601–610
Yu T, Chen X, Zhang W et al (2012) Regulation of the potential marker for intestinal cells, Bmi1, by beta-catenin and the zinc finger protein KLF4: implications for colon cancer. J Biol Chem 287:3760–3768
Yu F, Li J, Chen H et al (2011) Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 30:2161–2172
Zammarchi F, Morelli M, Menicagli M et al (2011) KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma. Am J Pathol 178:361–372
Zhang X, Cruz FD, Terry M, Remotti F, Matushansky I (2013) Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene 32:2249–2260, 2260.e1–21
Zhang X, Yang JJ, Kim YS, Kim KY, Ahn WS, Yang S (2010) An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer. Int J Oncol 36:405–414
Zhenzhen Z, De’an T, Limin X, Wei Y, Min L (2012) New candidate tumor-suppressor gene KLF6 and its splice variant KLF6 SV2 counterbalancing expression in primary hepatocarcinoma. Hepatogastroenterology 59:473–476
Acknowledgments
This work was supported by grants from Science and Technology Fund of Sichuan Province no. 2011SZ0096 and National Natural Science Foundation of China nos. 31470904 and 81030034.
Conflict of interest
The authors do not have any conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhang, Y., Hao, J., Zheng, Y. et al. Role of Krüppel-like factors in cancer stem cells. J Physiol Biochem 71, 155–164 (2015). https://doi.org/10.1007/s13105-015-0381-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-015-0381-4